Skip to main content

Table 1 Demographic data of studied group (44 children)

From: Delayed myocardial enhancement in children with different types of cardiomyopathy: a diagnostic and prognostic tool

  Mean SD (min-max)
Age/years 9.8 ± 5.6 (2–18)
Weight (in kg) 38.1 ± 23 (8–80)
Height (in cm) 124.2 ± 37.4 (60–178)
BSA 1.12 ± 0.51 (0.42–1.98)
Sex N %
 Male 18 40.9
 Female 26 59.1
Family history 5 11.4
Consanguinity 5 11.4
Major adverse effects* 14 31.8
  1. *Major adverse effects include hospitalization for HF (five cases), death (five cases), arrhythmia (three cases), and brain infarction (1 case)